News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Talks Up Its Pipeline


2/5/2014 10:58:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Drugs giant GlaxoSmithKline (LON:GSK) expects core earnings to grow by 4-8% this year on a constant exchange rates (CER) basis.

The group issued the guidance as it published fourth quarter and full year results that showed fourth quarter earnings per share in the core business rose 1% on a CER basis from a year earlier.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES